{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:54:06Z","timestamp":1793937246323,"version":"4.8.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI175869"],"award-info":[{"award-number":["R21AI175869"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI137276"],"award-info":[{"award-number":["R01AI137276"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P01AI148102"],"award-info":[{"award-number":["P01AI148102"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["2U19AI144306"],"award-info":[{"award-number":["2U19AI144306"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG085587"],"award-info":[{"award-number":["R01AG085587"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG085587"],"award-info":[{"award-number":["R01AG085587"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG085587"],"award-info":[{"award-number":["R01AG085587"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["208710\/Z\/17\/Z"],"award-info":[{"award-number":["208710\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67070-3","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T07:33:27Z","timestamp":1765524807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Asymmetrically glycosylated IgG1 antibodies are universal and drive human disease"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8739-7861","authenticated-orcid":false,"given":"Tala","family":"Azzam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos","family":"Bournazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8103-7846","authenticated-orcid":false,"given":"Hasret","family":"Gunduz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6661-1694","authenticated-orcid":false,"given":"Trevor","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1814-7049","authenticated-orcid":false,"given":"Maria W.","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily G.","family":"Niejadlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veasna","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trenton J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2010-5398","authenticated-orcid":false,"given":"Diego E.","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikri Y.","family":"Avci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0325-7990","authenticated-orcid":false,"given":"Wilbur A.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8911-1502","authenticated-orcid":false,"given":"Tineke","family":"Cantaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5466-0053","authenticated-orcid":false,"given":"Blaine R.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3250-3804","authenticated-orcid":false,"given":"Betty","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2024-9041","authenticated-orcid":false,"given":"Jeffrey V.","family":"Ravetch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7750-4413","authenticated-orcid":false,"given":"Jonathan J.","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0478-3033","authenticated-orcid":false,"given":"Eric J.","family":"Sundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"67070_CR1","doi-asserted-by":"publisher","first-page":"a013359","DOI":"10.1101\/cshperspect.a013359","volume":"5","author":"J Breitling","year":"2013","unstructured":"Breitling, J. & Aebi, M. N-linked protein glycosylation in the endoplasmic reticulum. Cold Spring Harb. Perspect. Biol. 5, a013359 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"67070_CR2","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","volume":"15","author":"C Reily","year":"2019","unstructured":"Reily, C., Stewart, T. J., Renfrow, M. B. & Novak, J. Glycosylation in health and disease. Nat. Rev. Nephrol. 15, 346\u2013366 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"67070_CR3","first-page":"63","volume":"423","author":"TT Wang","year":"2019","unstructured":"Wang, T. T. IgG Fc glycosylation in human immunity. Curr. Top. Microbiol. Immunol. 423, 63\u201375 (2019).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"67070_CR4","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3389\/fimmu.2017.00877","volume":"8","author":"G Dekkers","year":"2017","unstructured":"Dekkers, G. et al. Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor- and complement-mediated-effector activities. Front. Immunol. 8, 877 (2017).","journal-title":"Front. Immunol."},{"key":"67070_CR5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41581-024-00850-0","volume":"20","author":"A Beyze","year":"2024","unstructured":"Beyze, A., Larroque, C. & Le Quintrec, M. The role of antibody glycosylation in autoimmune and alloimmune kidney diseases. Nat. Rev. Nephrol. 20, 672\u2013689 (2024).","journal-title":"Nat. Rev. Nephrol."},{"key":"67070_CR6","doi-asserted-by":"publisher","first-page":"26733","DOI":"10.1074\/jbc.M202069200","volume":"277","author":"RL Shields","year":"2002","unstructured":"Shields, R. L. et al. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J. Biol. Chem. 277, 26733\u201326740 (2002).","journal-title":"J. Biol. Chem."},{"key":"67070_CR7","doi-asserted-by":"publisher","first-page":"18975","DOI":"10.1021\/ja208390n","volume":"133","author":"G Zou","year":"2011","unstructured":"Zou, G., Ochiai, H., Huang, W., Yang, Q., Li, C. & Wang, L. X. Chemoenzymatic synthesis and Fcgamma receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to FcgammaIIIa receptor. J. Am. Chem. Soc. 133, 18975\u201318991 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"67070_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.818736","volume":"13","author":"R Vattepu","year":"2022","unstructured":"Vattepu, R., Sneed, S. L. & Anthony, R. M. Sialylation as an important regulator of antibody function. Front. Immunol. 13, 818736 (2022).","journal-title":"Front. Immunol."},{"key":"67070_CR9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3389\/fimmu.2018.00553","volume":"9","author":"G Dekkers","year":"2018","unstructured":"Dekkers, G., Rispens, T. & Vidarsson, G. Novel concepts of altered immunoglobulin G galactosylation in autoimmune diseases. Front. Immunol. 9, 553 (2018).","journal-title":"Front. Immunol."},{"key":"67070_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nri2762","volume":"10","author":"KG Smith","year":"2010","unstructured":"Smith, K. G. & Clatworthy, M. R. FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat. Rev. Immunol. 10, 328\u2013343 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"67070_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cell.2015.06.026","volume":"162","author":"TT Wang","year":"2015","unstructured":"Wang, T. T. et al. Anti-HA glycoforms drive B cell affinity selection and determine influenza vaccine efficacy. Cell 162, 160\u2013169 (2015).","journal-title":"Cell"},{"key":"67070_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fimmu.2017.00646","volume":"8","author":"B Peschke","year":"2017","unstructured":"Peschke, B., Keller, C. W., Weber, P., Quast, I. & Lunemann, J. D. Fc-Galactosylation of human immunoglobulin gamma isotypes improves C1q binding and enhances complement-dependent cytotoxicity. Front. Immunol. 8, 646 (2017).","journal-title":"Front. Immunol."},{"key":"67070_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nm0395-237","volume":"1","author":"R Malhotra","year":"1995","unstructured":"Malhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A. & Sim, R. B. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat. Med. 1, 237\u2013243 (1995).","journal-title":"Nat. Med."},{"key":"67070_CR14","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/nm.2862","volume":"18","author":"CM Karsten","year":"2012","unstructured":"Karsten, C. M. et al. Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1. Nat. Med. 18, 1401\u20131406 (2012).","journal-title":"Nat. Med."},{"key":"67070_CR15","doi-asserted-by":"crossref","unstructured":"Markina Y. V. et al. Sialylated immunoglobulins for the treatment of immuno-inflammatory diseases. Int. J. Mol. Sci. 21, 5472 (2020).","DOI":"10.3390\/ijms21155472"},{"key":"67070_CR16","doi-asserted-by":"publisher","first-page":"5430","DOI":"10.7150\/thno.53961","volume":"11","author":"D Li","year":"2021","unstructured":"Li, D., Lou, Y., Zhang, Y., Liu, S., Li, J. & Tao, J. Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases. Theranostics 11, 5430\u20135446 (2021).","journal-title":"Theranostics"},{"key":"67070_CR17","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.11.041","volume":"172","author":"JD Pagan","year":"2018","unstructured":"Pagan, J. D., Kitaoka, M. & Anthony, R. M. Engineered sialylation of pathogenic antibodies in vivo attenuates autoimmune disease. Cell 172, 564\u2013577 e513 (2018).","journal-title":"Cell"},{"key":"67070_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/glycob\/cwaa018","volume":"30","author":"EB Irvine","year":"2020","unstructured":"Irvine, E. B. & Alter, G. Understanding the role of antibody glycosylation through the lens of severe viral and bacterial diseases. Glycobiology 30, 241\u2013253 (2020).","journal-title":"Glycobiology"},{"key":"67070_CR19","doi-asserted-by":"crossref","unstructured":"Haslund-Gourley B. S., Wigdahl B. & Comunale M. A. IgG N-glycan signatures as potential diagnostic and prognostic biomarkers. Diagnostics 13, 1016 (2023).","DOI":"10.3390\/diagnostics13061016"},{"key":"67070_CR20","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/art.27533","volume":"62","author":"A Ercan","year":"2010","unstructured":"Ercan, A. et al. Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum. 62, 2239\u20132248 (2010).","journal-title":"Arthritis Rheum."},{"key":"67070_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/cei.12527","volume":"178","author":"I Schwab","year":"2014","unstructured":"Schwab, I. & Nimmerjahn, F. Role of sialylation in the anti-inflammatory activity of intravenous immunoglobulin - F(ab\u2019)(2) versus Fc sialylation. Clin. Exp. Immunol. 178, 97\u201399 (2014).","journal-title":"Clin. Exp. Immunol."},{"key":"67070_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41590-020-00828-7","volume":"22","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty, S. et al. Proinflammatory IgG Fc structures in patients with severe COVID-19. Nat. Immunol. 22, 67\u201373 (2021).","journal-title":"Nat. Immunol."},{"key":"67070_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abm7853","volume":"14","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty, S. et al. Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity. Sci. Transl. Med. 14, eabm7853 (2022).","journal-title":"Sci. Transl. Med."},{"key":"67070_CR24","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1126\/science.abc7303","volume":"372","author":"S Bournazos","year":"2021","unstructured":"Bournazos, S. et al. Antibody fucosylation predicts disease severity in secondary dengue infection. Science 372, 1102\u20131105 (2021).","journal-title":"Science"},{"key":"67070_CR25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/19420862.2018.1466767","volume":"10","author":"NA Pereira","year":"2018","unstructured":"Pereira, N. A., Chan, K. F., Lin, P. C. & Song, Z. The \u201cless-is-more\u201d in therapeutic antibodies: afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity. mAbs 10, 693\u2013711 (2018).","journal-title":"mAbs"},{"key":"67070_CR26","doi-asserted-by":"publisher","first-page":"8841","DOI":"10.1021\/ac402068r","volume":"85","author":"H Stockmann","year":"2013","unstructured":"Stockmann, H., Adamczyk, B., Hayes, J. & Rudd, P. M. Automated, high-throughput IgG-antibody glycoprofiling platform. Anal. Chem. 85, 8841\u20138849 (2013).","journal-title":"Anal. Chem."},{"key":"67070_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ab.2007.08.012","volume":"370","author":"X Chen","year":"2007","unstructured":"Chen, X. & Flynn, G. C. Analysis of N-glycans from recombinant immunoglobulin G by on-line reversed-phase high-performance liquid chromatography\/mass spectrometry. Anal. Biochem. 370, 147\u2013161 (2007).","journal-title":"Anal. Biochem."},{"key":"67070_CR28","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/nprot.2018.024","volume":"13","author":"L Cao","year":"2018","unstructured":"Cao, L. et al. Global site-specific analysis of glycoprotein N-glycan processing. Nat. Protoc. 13, 1196\u20131212 (2018).","journal-title":"Nat. Protoc."},{"key":"67070_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2024.124068","volume":"1237","author":"Y Helali","year":"2024","unstructured":"Helali, Y. & Delporte, C. Updates of the current strategies of labeling for N-glycan analysis. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 1237, 124068 (2024).","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"67070_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s42004-024-01297-x","volume":"7","author":"I Senini","year":"2024","unstructured":"Senini, I. et al. Direct glycosylation analysis of intact monoclonal antibodies combining ESI MS of glycoforms and MALDI-in source decay MS of glycan fragments. Commun. Chem. 7, 203 (2024).","journal-title":"Commun. Chem."},{"key":"67070_CR31","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0014-5793(00)01557-X","volume":"473","author":"K Masuda","year":"2000","unstructured":"Masuda, K., Yamaguchi, Y., Kato, K., Takahashi, N., Shimada, I. & Arata, Y. Pairing of oligosaccharides in the Fc region of immunoglobulin G. FEBS Lett. 473, 349\u2013357 (2000).","journal-title":"FEBS Lett."},{"key":"67070_CR32","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1074\/jbc.M113.513366","volume":"289","author":"Z Liu","year":"2014","unstructured":"Liu, Z. et al. Asymmetrical Fc engineering greatly enhances antibody-dependent cellular cytotoxicity (ADCC) effector function and stability of the modified antibodies. J. Biol. Chem. 289, 3571\u20133590 (2014).","journal-title":"J. Biol. Chem."},{"key":"67070_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0019-2791(77)90194-X","volume":"14","author":"AC Wang","year":"1977","unstructured":"Wang, A. C. & Wang, I. Y. Cleavage sites of human IgG1 immunoglobulin by papain. Immunochemistry 14, 197\u2013200 (1977).","journal-title":"Immunochemistry"},{"key":"67070_CR34","doi-asserted-by":"publisher","first-page":"M111 010090","DOI":"10.1074\/mcp.M111.010090","volume":"10","author":"M Pucic","year":"2011","unstructured":"Pucic, M. et al. High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol. Cell Proteom. 10, M111 010090 (2011).","journal-title":"Mol. Cell Proteom."},{"key":"67070_CR35","doi-asserted-by":"publisher","first-page":"108169","DOI":"10.1016\/j.biotechadv.2023.108169","volume":"67","author":"S Shkunnikova","year":"2023","unstructured":"Shkunnikova, S., Mijakovac, A., Sironic, L., Hanic, M., Lauc, G. & Kavur, M. M. IgG glycans in health and disease: Prediction, intervention, prognosis, and therapy. Biotechnol. Adv. 67, 108169 (2023).","journal-title":"Biotechnol. Adv."},{"key":"67070_CR36","doi-asserted-by":"crossref","unstructured":"Mesonzhnik N., Belushenko A., Novikova P., Kukharenko A. & Afonin M. Enhanced N-glycan profiling of therapeutic monoclonal antibodies through the application of upper-hinge middle-up level LC-HRMS analysis. Antibodies 13, 66 (2024).","DOI":"10.3390\/antib13030066"},{"key":"67070_CR37","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1021\/acscentsci.8b00917","volume":"5","author":"EH Klontz","year":"2019","unstructured":"Klontz, E. H. et al. Molecular basis of broad spectrum N-glycan specificity and processing of therapeutic IgG monoclonal antibodies by endoglycosidase S2. ACS Cent. Sci. 5, 524\u2013538 (2019).","journal-title":"ACS Cent. Sci."},{"key":"67070_CR38","doi-asserted-by":"publisher","first-page":"332","DOI":"10.4161\/mabs.1.4.9122","volume":"1","author":"R Jefferis","year":"2009","unstructured":"Jefferis, R. & Lefranc, M. P. Human immunoglobulin allotypes: possible implications for immunogenicity. mAbs 1, 332\u2013338 (2009).","journal-title":"mAbs"},{"key":"67070_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/978-1-61779-842-9_34","volume":"882","author":"MP Lefranc","year":"2012","unstructured":"Lefranc, M. P. & Lefranc, G. Human Gm, Km, and Am allotypes and their molecular characterization: a remarkable demonstration of polymorphism. Methods Mol. Biol. 882, 635\u2013680 (2012).","journal-title":"Methods Mol. Biol."},{"key":"67070_CR40","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.molimm.2011.09.002","volume":"49","author":"AM Goetze","year":"2011","unstructured":"Goetze, A. M., Zhang, Z., Liu, L., Jacobsen, F. W. & Flynn, G. C. Rapid LC-MS screening for IgG Fc modifications and allelic variants in blood. Mol. Immunol. 49, 338\u2013352 (2011).","journal-title":"Mol. Immunol."},{"key":"67070_CR41","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jasms.2006.02.023","volume":"17","author":"HS Gadgil","year":"2006","unstructured":"Gadgil, H. S., Pipes, G. D., Dillon, T. M., Treuheit, M. J. & Bondarenko, P. V. Improving mass accuracy of high performance liquid chromatography\/electrospray ionization time-of-flight mass spectrometry of intact antibodies. J. Am. Soc. Mass Spectrom. 17, 867\u2013872 (2006).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"67070_CR42","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1021\/bi500203p","volume":"53","author":"LL Cheng","year":"2014","unstructured":"Cheng, L. L., Shidmoossavee, F. S. & Bennet, A. J. Neuraminidase substrate promiscuity permits a mutant Micromonospora viridifaciens enzyme to synthesize artificial carbohydrates. Biochemistry 53, 3982\u20133989 (2014).","journal-title":"Biochemistry"},{"key":"67070_CR43","doi-asserted-by":"publisher","first-page":"e1004364","DOI":"10.1371\/journal.ppat.1004364","volume":"10","author":"AK Singh","year":"2014","unstructured":"Singh, A. K. et al. Unravelling the multiple functions of the architecturally intricate Streptococcus pneumoniae beta-galactosidase, BgaA. PLoS Pathog. 10, e1004364 (2014).","journal-title":"PLoS Pathog."},{"key":"67070_CR44","doi-asserted-by":"publisher","first-page":"7359","DOI":"10.1038\/sj.onc.1206939","volume":"22","author":"MR Smith","year":"2003","unstructured":"Smith, M. R. Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance. Oncogene 22, 7359\u20137368 (2003).","journal-title":"Oncogene"},{"key":"67070_CR45","doi-asserted-by":"crossref","unstructured":"Lefranc M.-P. Chapter 26 - IMGT\u00ae Immunoglobulin repertoire analysis and antibody humanization. in Molecular Biology of B Cells 2nd edn (eds Alt F. W., Honjo T., Radbruch A. & Reth M.) (Academic Press, 2015).","DOI":"10.1016\/B978-0-12-397933-9.00026-6"},{"key":"67070_CR46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2123002119","volume":"119","author":"A Gupta","year":"2022","unstructured":"Gupta, A., Smith, P., Bournazos, S. & Ravetch, J. V. A novel mouse strain optimized for chronic human antibody administration. Proc. Natl. Acad. Sci. USA 119, e2123002119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67070_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20044-z","volume":"11","author":"EH Klontz","year":"2020","unstructured":"Klontz, E. H. et al. Structure and dynamics of an alpha-fucosidase reveal a mechanism for highly efficient IgG transfucosylation. Nat. Commun. 11, 6204 (2020).","journal-title":"Nat. Commun."},{"key":"67070_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1347871","volume":"15","author":"C Gstottner","year":"2024","unstructured":"Gstottner, C. et al. Benchmarking glycoform-resolved affinity separation - mass spectrometry assays for studying FcgammaRIIIa binding. Front. Immunol. 15, 1347871 (2024).","journal-title":"Front. Immunol."},{"key":"67070_CR49","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41564-023-01421-y","volume":"8","author":"R Yamin","year":"2023","unstructured":"Yamin, R. et al. Human FcgammaRIIIa activation on splenic macrophages drives dengue pathogenesis in mice. Nat. Microbiol 8, 1468\u20131479 (2023).","journal-title":"Nat. Microbiol"},{"key":"67070_CR50","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nbt0798-677","volume":"16","author":"AM Merchant","year":"1998","unstructured":"Merchant, A. M. et al. An efficient route to human bispecific IgG. Nat. Biotechnol. 16, 677\u2013681 (1998).","journal-title":"Nat. Biotechnol."},{"key":"67070_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60986-w","volume":"16","author":"DE Sastre","year":"2025","unstructured":"Sastre, D. E. et al. The mechanistic basis for interprotomer deglycosylation of antibodies by corynebacterial IgG-specific endoglycosidases. Nat. Commun. 16, 6147 (2025).","journal-title":"Nat. Commun."},{"key":"67070_CR52","doi-asserted-by":"publisher","first-page":"6994","DOI":"10.1016\/j.cell.2024.09.038","volume":"187","author":"DE Sastre","year":"2024","unstructured":"Sastre, D. E. et al. Potent efficacy of an IgG-specific endoglycosidase against IgG-mediated pathologies. Cell 187, 6994\u20137007 e6912 (2024).","journal-title":"Cell"},{"key":"67070_CR53","doi-asserted-by":"publisher","first-page":"16508","DOI":"10.1074\/jbc.M116.738765","volume":"291","author":"T Li","year":"2016","unstructured":"Li, T., Tong, X., Yang, Q., Giddens, J. P. & Wang, L. X. Glycosynthase mutants of endoglycosidase S2 show potent transglycosylation activity and remarkably relaxed substrate specificity for antibody glycosylation remodeling. J. Biol. Chem. 291, 16508\u201316518 (2016).","journal-title":"J. Biol. Chem."},{"key":"67070_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/srep36964","volume":"6","author":"G Dekkers","year":"2016","unstructured":"Dekkers, G. et al. Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans. Sci. Rep. 6, 36964 (2016).","journal-title":"Sci. Rep."},{"key":"67070_CR55","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","volume":"113","author":"P Bruhns","year":"2009","unstructured":"Bruhns, P. et al. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 113, 3716\u20133725 (2009).","journal-title":"Blood"},{"key":"67070_CR56","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/j.1365-2443.2011.01552.x","volume":"16","author":"T Mizushima","year":"2011","unstructured":"Mizushima, T. et al. Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans. Genes Cells 16, 1071\u20131080 (2011).","journal-title":"Genes Cells"},{"key":"67070_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13845-8","volume":"7","author":"Y Sakae","year":"2017","unstructured":"Sakae, Y. et al. Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcgamma receptor IIIa. Sci. Rep. 7, 13780 (2017).","journal-title":"Sci. Rep."},{"key":"67070_CR58","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1021\/acschembio.8b00342","volume":"13","author":"DJ Falconer","year":"2018","unstructured":"Falconer, D. J., Subedi, G. P., Marcella, A. M. & Barb, A. W. Antibody fucosylation lowers the FcgammaRIIIa\/CD16a affinity by limiting the conformations sampled by the N162-glycan. ACS Chem. Biol. 13, 2179\u20132189 (2018).","journal-title":"ACS Chem. Biol."},{"key":"67070_CR59","doi-asserted-by":"crossref","unstructured":"Keith, A. D. et al. Mapping affinity and allostery in human IgG antibody Fc region-Fc gamma receptor interactions. Preprint at bioRxiv https:\/\/www.biorxiv.org\/content\/10.1101\/2025.03.28.645945v1 (2025).","DOI":"10.1101\/2025.03.28.645945"},{"key":"67070_CR60","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.4049\/jimmunol.2400447","volume":"213","author":"B Radovani","year":"2024","unstructured":"Radovani, B. & Nimmerjahn, F. IgG glycosylation: biomarker, functional modulator, and structural component. J. Immunol. 213, 1573\u20131584 (2024).","journal-title":"J. Immunol."},{"key":"67070_CR61","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri.2017.106","volume":"18","author":"LL Lu","year":"2018","unstructured":"Lu, L. L., Suscovich, T. J., Fortune, S. M. & Alter, G. Beyond binding: antibody effector functions in infectious diseases. Nat. Rev. Immunol. 18, 46\u201361 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"67070_CR62","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc3930","volume":"15","author":"GJ Weiner","year":"2015","unstructured":"Weiner, G. J. Building better monoclonal antibody-based therapeutics. Nat. Rev. Cancer 15, 361\u2013370 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"67070_CR63","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-biochem-062917-012911","volume":"88","author":"LX Wang","year":"2019","unstructured":"Wang, L. X., Tong, X., Li, C., Giddens, J. P. & Li, T. Glycoengineering of antibodies for modulating functions. Annu Rev. Biochem 88, 433\u2013459 (2019).","journal-title":"Annu Rev. Biochem"},{"key":"67070_CR64","doi-asserted-by":"publisher","first-page":"12669","DOI":"10.1073\/pnas.1108455108","volume":"108","author":"C Ferrara","year":"2011","unstructured":"Ferrara, C. et al. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose. Proc. Natl. Acad. Sci. USA 108, 12669\u201312674 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67070_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2019.460554","volume":"1610","author":"A Freimoser-Grundschober","year":"2020","unstructured":"Freimoser-Grundschober, A. et al. FcgammaRIIIa chromatography to enrich a-fucosylated glycoforms and assess the potency of glycoengineered therapeutic antibodies. J. Chromatogr. A 1610, 460554 (2020).","journal-title":"J. Chromatogr. A"},{"key":"67070_CR66","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2021.1982847","volume":"13","author":"S Lippold","year":"2021","unstructured":"Lippold, S. et al. Fc gamma receptor IIIb binding of individual antibody proteoforms resolved by affinity chromatography-mass spectrometry. mAbs 13, 1982847 (2021).","journal-title":"mAbs"},{"key":"67070_CR67","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1080\/19420862.2019.1636602","volume":"11","author":"S Lippold","year":"2019","unstructured":"Lippold, S. et al. Glycoform-resolved Fc\u0263RIIIa affinity chromatography-mass spectrometry. mAbs 11, 1191\u20131196 (2019).","journal-title":"mAbs"},{"key":"67070_CR68","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1074\/mcp.RA119.001607","volume":"18","author":"KR Patel","year":"2019","unstructured":"Patel, K. R., Nott, J. D. & Barb, A. W. primary human natural killer cells retain proinflammatory IgG1 at the cell surface and express CD16a glycoforms with donor-dependent variability. Mol. Cell Proteom. 18, 2178\u20132190 (2019).","journal-title":"Mol. Cell Proteom."},{"key":"67070_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.929895","volume":"13","author":"J Golay","year":"2022","unstructured":"Golay, J., Andrea, A. E. & Cattaneo, I. Role of Fc core fucosylation in the effector function of IgG1 antibodies. Front. Immunol. 13, 929895 (2022).","journal-title":"Front. Immunol."},{"key":"67070_CR70","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.molimm.2012.02.111","volume":"51","author":"S Schneider","year":"2012","unstructured":"Schneider, S. & Zacharias, M. Atomic resolution model of the antibody Fc interaction with the complement C1q component. Mol. Immunol. 51, 66\u201372 (2012).","journal-title":"Mol. Immunol."},{"key":"67070_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46484-2","volume":"9","author":"AR Temming","year":"2019","unstructured":"Temming, A. R. et al. Human DC-SIGN and CD23 do not interact with human IgG. Sci. Rep. 9, 9995 (2019).","journal-title":"Sci. Rep."},{"key":"67070_CR72","doi-asserted-by":"crossref","unstructured":"Jones, A. T., Marino, A. E., Martynyuk, T., Bournazos, S., Ravetch, J. V. The anti-inflammatory activity of IgG is enhanced by co-engagement of type I and II Fc receptors. Science 390, eadv2927 (2025).","DOI":"10.1126\/science.adv2927"},{"key":"67070_CR73","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/imr.13407","volume":"328","author":"J Kristic","year":"2024","unstructured":"Kristic, J. & Lauc, G. The importance of IgG glycosylation-What did we learn after analyzing over 100,000 individuals. Immunol. Rev. 328, 143\u2013170 (2024).","journal-title":"Immunol. Rev."},{"key":"67070_CR74","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean, B. et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966\u2013968 (2010).","journal-title":"Bioinformatics"},{"key":"67070_CR75","unstructured":"World Health O. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. WHO, Geneva, (1997)."},{"key":"67070_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2020.113862","volume":"282","author":"TP Ou","year":"2020","unstructured":"Ou, T. P. et al. Improved detection of dengue and Zika viruses using multiplex RT-qPCR assays. J. Virol. Methods 282, 113862 (2020).","journal-title":"J. Virol. Methods"},{"key":"67070_CR77","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.1073\/pnas.1203954109","volume":"109","author":"P Smith","year":"2012","unstructured":"Smith, P., DiLillo, D. J., Bournazos, S., Li, F. & Ravetch, J. V. Mouse model recapitulating human Fc\u03b3 receptor structural and functional diversity. Proc. Natl. Acad. Sci. USA 109, 6181\u20136186 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67070_CR78","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41564-023-01421-y","volume":"8","author":"R Yamin","year":"2023","unstructured":"Yamin, R. et al. Human Fc\u03b3RIIIa activation on splenic macrophages drives dengue pathogenesis in mice. Nat. Microbiol. 8, 1468\u20131479 (2023).","journal-title":"Nat. Microbiol."},{"key":"67070_CR79","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol, Y. et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 53, D543\u2013D553 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67070-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67070-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67070-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:13:19Z","timestamp":1768342399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67070-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67070"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67070-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.A., D.E.S., J.J.D., and E.J.S. are inventors on a provisional patent application filed with the United States Patent and Trademark Office by Emory University relevant to the work in this manuscript. All other authors declare they have no competing interests.\u00a0","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"383"}}